Phase III trial of postoperative cisplatin, interferon alpha-2b, and 5-FU combined with external radiation treatment versus 5-FU alone for patients with resected pancreatic adenocarcinoma – CapRI: study protocol [ISRCTN62866759]

After surgical intervention with curative intention in specialised centres the five-year survival of patients with carcinoma of the exocrine pancreas is only 15%. The ESPAC-1 trial showed an increased five-year survival of 21% achieved with adjuvant chemotherapy. Investigators from the Virginia Maso...

Descripción completa

Detalles Bibliográficos
Autores principales: Knaebel, HP, Märten, A, Schmidt, J, Hoffmann, K, Seiler, C, Lindel, K, Schmitz-Winnenthal, H, Fritz, S, Herrmann, T, Goldschmidt, H, Mansmann, U, Debus, J, Diehl, V, Büchler, MW
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1087479/
https://www.ncbi.nlm.nih.gov/pubmed/15826316
http://dx.doi.org/10.1186/1471-2407-5-37

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1087479/
https://www.ncbi.nlm.nih.gov/pubmed/15826316
http://dx.doi.org/10.1186/1471-2407-5-37

Ejemplares similares